Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boess Carsten
Relationship:   Director
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   125,791    

Indirect Shares

   0      
Direct Value   $5,848,912    

Indirect Value

   $0      
Total Shares   125,791      
Total Value   $5,848,912      


Alexion Pharmaceuticals Inc $912,500 Insulet Corp $3,284,748 Kiniksa Pharmaceuticals, Ltd. $1,533,680 Orchestra BioMed Holdings Inc. $117,983 Alexion Pharmaceuticals Inc $912,500 Insulet Corp $3,284,748 Kiniksa Pharmaceuticals, Ltd. $1,533,680 Orchestra BioMed Holdings Inc. $117,983
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN Former CFO 2005-06-27 5,000 2005-03-09 0    Premium*  
            Insulet Corp PODD Vice President, Intern... 2011-04-25 18,941 2007-12-03 0    Premium*  
            Synageva BioPharma Corp GEVA SVP, Chief Financial O... 2015-06-22 0 2012-07-18 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 10% Owner 2018-05-29 79,589 2018-05-29 0    Premium*  
            Orchestra BioMed Holdings Inc. OBIO Director 2020-08-03 22,261 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... Former Chief Financial Officer   –       –      –    2005-06-27 4 S $23.27 $263,178 D/D (11,250) 0 -
ALXN Alexion Pharmaceuticals I... Former CFO   –       –      –    2005-06-27 4/A S $23.27 $145,828 D/D (6,250) 5,000 -
ALXN Alexion Pharmaceuticals I... Former CFO   –       –      –    2005-06-27 4/A OE $23.39 $263,178 D/D 11,250 11,250 -
PODD Insulet Corp Chief Financial Officer   •       –      –    2007-12-03 4 OE $8.04 $201,000 D/D 25,000 25,000 0 -
PODD Insulet Corp Chief Financial Officer   •       –      –    2007-12-04 4 OE $8.04 $17,688 D/D 2,200 2,200 0 -
PODD Insulet Corp Chief Financial Officer   •       –      –    2007-12-05 4 OE $8.04 $57,510 D/D 7,153 7,153 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-01-18 4 OE $6.83 $71,223 D/D 10,428 20,428 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-02-02 4 OE $6.83 $247,219 D/D 31,813 41,813 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-02-07 4 OE $8.04 $40,650 D/D 5,056 15,056 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-03-24 4 OE $8.04 $252,424 D/D 31,396 50,337 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-03-25 4 OE $8.04 $127,836 D/D 15,900 34,841 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-03-29 4 OE $8.04 $284,584 D/D 35,396 54,337 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-03-30 4 OE $8.04 $95,676 D/D 11,900 30,841 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-04-18 4 OE $8.04 $48,240 D/D 6,000 24,941 0 -
PODD Insulet Corp Vice President, International   •       –      –    2011-04-25 4 OE $8.04 $332,020 D/D 41,296 60,237 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2012-07-18 4 OE $1.70 $11,251 D/D 6,618 6,618 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2012-10-16 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-01-16 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-07-11 4 OE $1.70 $22,503 D/D 13,237 13,237 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-16 4 OE $1.70 $7,310 D/D 4,300 4,300 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-20 4 OE $1.70 $59,545 D/D 7,800 7,800 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-08-21 4 OE $23.00 $153,663 D/D 6,681 6,681 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2013-11-18 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-02-18 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
GEVA Synageva BioPharma Corp SVP, Chief Financial Officer   •       –      –    2014-05-16 4 OE $1.70 $16,876 D/D 9,927 9,927 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us